Euclidean Capital LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001825034 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 12, 2021

Total Value: $472M (100.0% shares, 0.0% debt)

Holdings (10)

PMVP PMV PHARMACEUTICALS INC 54.4%

Value $257M Shares 4,179,416 Est. Cost $39.23 Unrealized 0.0%

— NGM BIOPHARMACEUTICALS INC 13.4%

Value $63.13M Shares 2,083,602 Est. Cost $30.30 Unrealized —

ORIC ORIC PHARMACEUTICALS INC 10.0%

Value $47.41M Shares 1,400,435 Est. Cost $28.69 Unrealized 0.0%

DNLI DENALI THERAPEUTICS INC 5.7%

Value $27.12M Shares 323,749 Est. Cost $60.45 Unrealized 0.0%

FHTX FOGHORN THERAPEUTICS INC 5.4%

Value $25.57M Shares 1,261,261 Est. Cost $19.16 Unrealized 0.0%

— CONSTELLATION PHARMCETICLS I 3.4%

Value $15.96M Shares 554,325 Est. Cost $28.80 Unrealized —

ALEC ALECTOR INC 3.1%

Value $14.84M Shares 980,894 Est. Cost $12.43 Unrealized 0.0%

— RAPT THERAPEUTICS INC 3.1%

Value $14.53M Shares 735,801 Est. Cost $19.75 Unrealized —

RVMD REVOLUTION MEDICINES INC 0.8%

Value $3.699M Shares 93,436 Est. Cost $39.54 Unrealized 0.0%

FFBC FIRST FINL BANCORP OH 0.6%

Value $3.043M Shares 173,576 Est. Cost $12.77 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PMVP	PMV PHARMACEUTICALS INC	4,179,416	$257M	54.4%	$39.23	0.0%	COM	69353Y103
—	NGM BIOPHARMACEUTICALS INC	2,083,602	$63.13M	13.4%	$30.30	—	COM	62921N105
ORIC	ORIC PHARMACEUTICALS INC	1,400,435	$47.41M	10.0%	$28.69	0.0%	COM	68622P109
DNLI	DENALI THERAPEUTICS INC	323,749	$27.12M	5.7%	$60.45	0.0%	COM	24823R105
FHTX	FOGHORN THERAPEUTICS INC	1,261,261	$25.57M	5.4%	$19.16	0.0%	COM	344174107
—	CONSTELLATION PHARMCETICLS I	554,325	$15.96M	3.4%	$28.80	—	COM	210373106
ALEC	ALECTOR INC	980,894	$14.84M	3.1%	$12.43	0.0%	COM	014442107
—	RAPT THERAPEUTICS INC	735,801	$14.53M	3.1%	$19.75	—	COM	75382E109
RVMD	REVOLUTION MEDICINES INC	93,436	$3.699M	0.8%	$39.54	0.0%	COM	76155X100
FFBC	FIRST FINL BANCORP OH	173,576	$3.043M	0.6%	$12.77	0.0%	COM	320209109